Gold Investment Management’s AstraZeneca AZN Stock Holding History

Gold Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.9K	Hold	10	–	–	﹤0.01%	192
2026 Q1	$1.97K	Hold	10	–	–	﹤0.01%	190
2025 Q4	$1.84K	Hold	10	–	–	﹤0.01%	193
2025 Q3	$1.53K	Hold	10	–	–	﹤0.01%	192
2025 Q2	$1.43K	Hold	10	–	–	﹤0.01%	195
2025 Q1	$1.47K	Hold	10	–	–	﹤0.01%	206
2024 Q4	$1.31K	Hold	10	–	–	﹤0.01%	208
2024 Q3	$1.56K	Hold	10	–	–	﹤0.01%	201
2024 Q2	$1.56K	Hold	10	–	–	﹤0.01%	203
2024 Q1	$1.35K	Hold	10	–	–	﹤0.01%	203
2023 Q4	$1.35K	Buy	+10	New	+$1.3K	﹤0.01%	200

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gold Investment Management's AZN Position: Q2 2026 in Review

Gold Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 10 shares worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #192.

Gold Investment Management first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.97K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Gold Investment Management held 10 shares of AstraZeneca worth $1.9K as of Q2 2026.
Gold Investment Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Gold Investment Management's portfolio in Q2 2026, its #192 holding.
Gold Investment Management first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Gold Investment Management's AstraZeneca position peaked at $1.97K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gold Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.